疫苗储存设备市场－全球产业规模、份额、趋势、机会及预测（按产品、类型、最终用户、地区和竞争格局划分，2021-2031年）

全球疫苗储存设备市场预计将从 2025 年的 12.1 亿美元成长到 2031 年的 16.7 亿美元，复合年增长率为 5.52%。

此细分市场涵盖专业的低温运输解决方案，包括医用冷藏库和用于在精确温度下储存生物製品的保温容器。成长的主要驱动力是国际疫苗宣传活动的加速推进，以及发展中国家对温控疫苗物流基础设施的需求。此外，从老旧冷冻设备转向太阳能製冷系统的策略转型也持续推动市场需求。例如，联合国儿童基金会报告称，将在2024年采购价值1.108亿美元的低温运输设备，以加强这项关键的全球卫生基础设施。

市场发展面临的主要障碍之一是偏远地区长期缺乏可靠的电力供应和技术维护专业知识。基础设施的匮乏导致设备频繁故障和库存浪费，阻碍了对现代储能技术的投资。因此，对于希望扩大市场份额的相关人员而言，建立能够保障这些资产使用寿命的永续服务网络仍然是一项复杂的挑战。

市场驱动因素

政府加大对免疫接种计画的主导和倡议，正透过不断提高低温运输需求，从根本上改变全球疫苗储存设备市场。国际组织和各国卫生署正致力于扩大疫苗接种覆盖范围，涵盖未接种疫苗和接种率低的地区，这使得整个供应链需要强大的储存基础设施。根据Shot@Life于2025年7月发布的《2024年免疫接种数据分析》，预计到2024年，全球将成功为约1.15亿名婴儿接种第一剂百白破疫苗。如此庞大的接种规模，使得从生产到最终交付，对确保疫苗有效性的医用冷藏库和冷冻库的需求持续旺盛。

同时，永续且节能的储能係统正日益受到关注，以解决电力供应不稳定地区的基础设施短缺问题。技术进步正推动太阳能直驱（SDD）装置的广泛应用，不仅降低了营运成本，还无需更换电池。根据联合国儿童基金会于2025年5月发布的《2024年度供应报告》，2024年采购了1,500套太阳能係统，用于为医疗机构供电，并确保疫苗储存的稳定电力供应。这项转变对于管理复杂的生物製药库存至关重要；世界卫生组织（世卫组织）2024年的报告估计，全球市场上有88种疫苗产品需要严格的温度控制。

市场挑战

偏远地区持续缺乏可靠的电力供应和技术维护资源，严重限制了疫苗储存设备的潜在市场。由于现代医用冷藏库需要稳定的电力供应才能维持严格的温度控制，製造商难以在能源匮乏地区部署这些解决方案。这种基础设施的不足迫使医疗机构继续使用过时、低效的冷却方式，而不是投资购买新的电气设备，从而有效地阻碍了本应需求最高的、高需求发展中国家的潜在销售量。

此外，这些缺陷导致的营运不稳定使得采购机构在财务方面格外谨慎。维护不善和电力突波造成的频繁设备故障导致昂贵疫苗的浪费，并耗尽了原本可用于基础设施升级的资金。世界卫生组织（世卫组织）的数据显示，到2023年，约有10亿低收入和中低收入国家的人口在缺乏可靠电力供应的医疗机构就诊。这种普遍存在的电力不稳定造成了高风险环境，阻碍了相关人员对先进储存技术的投资，直接限制了市场成长。

市场趋势

物联网即时监控系统的整合正迅速成为一项标准营运要求，使关注点从被动数据记录转向主动风险缓解。相关人员正在部署云端连接感测器，以实现端到端的可视性，使物流经理能够即时应对温度异常，而不是在交付后才发现废弃物。这项技术变革的驱动力在于利用详细、可操作的数据来保护高价值生物资产，从而加速智慧追踪解决方案在整个医药供应链中的应用。例如，Controlant 在 2025 年 5 月的「年度会议成果」新闻稿中报告称，其 2024 年核心收入增长超过 50%，并将此归因于全球对这类即时供应链可视性解决方案的强劲需求。

同时，随着製造商适应日益严格的全球环境法规，环保天然冷媒的使用正在重新定义产品开发。各公司正积极以碳氢化合物基替代品取代具有高全球暖化潜势 (GWP) 的氢氟碳化合物 (HFC)，这些替代品具有更高的热效率和显着更低的碳足迹。这种转变是一项双重策略：既满足永续性合规要求，又透过提高压缩机性能来降低医疗机构的长期营运成本。 2025 年 5 月，海尔生物医疗在报导中宣布，其全新「UltraECO」系列产品采用完全不含氢氟碳化合物的绿色隔热材料，可降低高达 50% 的能耗。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球疫苗储存设备市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品类型（冷藏箱、耗材及配件、发泡聚苯乙烯泡沫冰袋、冷冻库（低温冷冻库、超低温冷冻库）、监控设备、冷藏库（大容量、小容量）、疫苗运输箱）
  • 依类型（冷藏保管、冷藏运送）
  • 依最终用户（分销/物流、医院/医疗机构、零售商）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章 北美疫苗储存设备市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲疫苗储存设备市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区疫苗储存设备市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲疫苗储存设备市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲疫苗储存设备市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球疫苗储存设备市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• American Biotech Supply
• Arctiko A/S
• Eppendorf AG
• Evermed SRL
• Qingdao Haier Biomedical Co., Ltd.
• Helmer Scientific Inc,
• Labcold Limited
• Panasonic Healthcare Co., Ltd
• Philips Kirsch Gmbh
• Thermo Fisher Scientific, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Vaccine Storage Equipment Market is projected to expand from USD 1.21 Billion in 2025 to USD 1.67 Billion by 2031, registering a CAGR of 5.52%. This sector encompasses specialized cold chain solutions, including medical-grade refrigerators and insulated containers designed to preserve biological products at precise temperatures. Growth is largely fueled by the acceleration of international immunization campaigns and the logistical necessities of distributing temperature-sensitive vaccines in developing nations. Furthermore, the strategic transition from obsolete cooling units to solar direct drive systems continues to stimulate market demand. For instance, UNICEF reported procuring cold chain equipment worth 110.8 million United States dollars in 2024 to bolster this essential global health infrastructure.

A significant obstacle hindering market progression is the persistent unavailability of reliable electricity and technical maintenance expertise in remote locations. This lack of infrastructure frequently causes equipment malfunctions and inventory wastage, which discourages investment in modern electric storage technologies. Consequently, establishing sustainable service networks capable of ensuring the operational longevity of these assets remains a complex challenge for stakeholders aiming to broaden their market presence.

Market Driver

Rising government initiatives and increased funding for immunization programs are fundamentally transforming the global vaccine storage equipment market by escalating cold chain requirements. International bodies and national health ministries are focusing on expanding vaccine coverage to reach zero-dose and under-immunized communities, creating a need for robust storage infrastructure throughout the supply chain. According to a July 2025 article by Shot@Life titled 'Unpacking the Immunization Data of 2024', global efforts successfully administered at least one dose of the DTP vaccine to an estimated 115 million infants in 2024. This massive operational volume sustains the demand for medical-grade refrigerators and freezers to guarantee vaccine potency from production to final delivery.

Concurrently, there is a growing emphasis on sustainable, energy-efficient storage systems to address infrastructure deficits in areas with unstable power supplies. Technological progress has spurred the widespread adoption of Solar Direct Drive (SDD) units, which reduce operational costs and eliminate the need for battery replacements. The UNICEF Supply Annual Report 2024, released in May 2025, noted the procurement of 1,500 solar systems in 2024 specifically to solarize health facilities and ensure reliable power for vaccine storage. This transition is essential for managing the complex inventory of biologicals, with the World Health Organization reporting in 2024 that the global market included 88 vaccine products requiring strict temperature management.

Market Challenge

The continued absence of dependable electricity and technical maintenance resources in remote regions severely limits the addressable market for vaccine storage equipment. Because modern medical-grade refrigerators require consistent power to maintain strict temperature controls, manufacturers face difficulties deploying these solutions in areas affected by energy poverty. This infrastructural gap compels health networks to prolong the use of outdated, less efficient cooling methods rather than investing in new electric units, effectively stalling potential sales volumes in high-need developing nations where the demand is theoretically greatest.

Furthermore, operational instability resulting from these deficiencies fosters significant financial caution among procurement agencies. Frequent equipment breakdowns caused by inadequate maintenance or power surges lead to expensive vaccine spoilage, depleting funds that could otherwise support infrastructure upgrades. According to the World Health Organization, nearly 1 billion people in low- and lower-middle-income countries were served by health facilities lacking reliable electricity in 2023. This widespread unreliability creates a high-risk environment that discourages stakeholders from investing in advanced storage technologies, thereby directly suppressing market growth.

Market Trends

The integration of IoT-enabled real-time monitoring systems is fast becoming a standard operational necessity, shifting the focus from passive data logging to active risk mitigation. Stakeholders are implementing cloud-connected sensors to gain end-to-end visibility, enabling logistics managers to address temperature excursions immediately rather than detecting spoilage after delivery. This technological evolution is driven by the necessity to protect high-value biological assets using granular, actionable data, accelerating the adoption of smart tracking solutions across the pharmaceutical supply chain. For instance, Controlant reported in a May 2025 press release titled 'Annual Meeting Results' that the company experienced over 50% growth in core revenues for 2024, attributed specifically to the strong global demand for these real-time supply chain visibility solutions.

Simultaneously, the utilization of eco-friendly natural refrigerants is redefining product development as manufacturers adapt to stringent global environmental regulations. Companies are actively replacing high-Global Warming Potential (GWP) hydrofluorocarbons with hydrocarbon-based alternatives, which provide superior thermal efficiency and significantly lower carbon footprints. This shift functions as a dual-purpose strategy to satisfy sustainability compliance mandates while reducing long-term operating costs for healthcare facilities through enhanced compressor performance. In May 2025, Haier Biomedical announced in an article titled 'Haier Biomedical sets new standard for energy efficient ULT storage' that their new UltraECO range achieves up to a 50% reduction in energy usage by employing green insulation materials entirely free from harmful hydrofluorocarbons.

Key Market Players

• American Biotech Supply
• Arctiko A/S
• Eppendorf AG
• Evermed S.R.L.
• Qingdao Haier Biomedical Co., Ltd.
• Helmer Scientific Inc,
• Labcold Limited
• Panasonic Healthcare Co., Ltd
• Philips Kirsch Gmbh
• Thermo Fisher Scientific, Inc.

Report Scope

In this report, the Global Vaccine Storage Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vaccine Storage Equipment Market, By Product

• Cold Boxes
• Consumables & Accessories
• Foam Pads
• Freezer(Low-Temperature Freezers, Ultra-low Temperature Freezers)
• Monitoring Device
• Refrigerator(Large Capacity, Small Capacity)
• Vaccine Carriers

Vaccine Storage Equipment Market, By Type

• Refrigerated Storage
• Refrigerated Transport

Vaccine Storage Equipment Market, By End user

• Distributor & Logistics
• Hospitals & Medical Institutes
• Retailer

Vaccine Storage Equipment Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vaccine Storage Equipment Market.

Available Customizations:

Global Vaccine Storage Equipment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vaccine Storage Equipment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Cold Boxes, Consumables & Accessories, Foam Pads, Freezer(Low-Temperature Freezers, Ultra-low Temperature Freezers), Monitoring Device, Refrigerator(Large Capacity, Small Capacity), Vaccine Carriers)
  • 5.2.2. By Type (Refrigerated Storage, Refrigerated Transport)
  • 5.2.3. By End user (Distributor & Logistics, Hospitals & Medical Institutes, Retailer)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Vaccine Storage Equipment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By End user
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vaccine Storage Equipment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By End user
  • 6.3.2. Canada Vaccine Storage Equipment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By End user
  • 6.3.3. Mexico Vaccine Storage Equipment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By End user

7. Europe Vaccine Storage Equipment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By End user
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vaccine Storage Equipment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By End user
  • 7.3.2. France Vaccine Storage Equipment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By End user
  • 7.3.3. United Kingdom Vaccine Storage Equipment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By End user
  • 7.3.4. Italy Vaccine Storage Equipment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By End user
  • 7.3.5. Spain Vaccine Storage Equipment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By End user

8. Asia Pacific Vaccine Storage Equipment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By End user
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Vaccine Storage Equipment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By End user
  • 8.3.2. India Vaccine Storage Equipment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By End user
  • 8.3.3. Japan Vaccine Storage Equipment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By End user
  • 8.3.4. South Korea Vaccine Storage Equipment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By End user
  • 8.3.5. Australia Vaccine Storage Equipment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By End user

9. Middle East & Africa Vaccine Storage Equipment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By End user
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Vaccine Storage Equipment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By End user
  • 9.3.2. UAE Vaccine Storage Equipment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By End user
  • 9.3.3. South Africa Vaccine Storage Equipment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By End user

10. South America Vaccine Storage Equipment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By End user
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Vaccine Storage Equipment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By End user
  • 10.3.2. Colombia Vaccine Storage Equipment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By End user
  • 10.3.3. Argentina Vaccine Storage Equipment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By End user

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Vaccine Storage Equipment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. American Biotech Supply
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Arctiko A/S
• 15.3. Eppendorf AG
• 15.4. Evermed S.R.L.
• 15.5. Qingdao Haier Biomedical Co., Ltd.
• 15.6. Helmer Scientific Inc,
• 15.7. Labcold Limited
• 15.8. Panasonic Healthcare Co., Ltd
• 15.9. Philips Kirsch Gmbh
• 15.10. Thermo Fisher Scientific, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer